Involvement of agmatine in antidepressant-like effect of HMG-CoA reductase inhibitors in mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Involvement of agmatine in antidepressant-like effect of HMG-CoA reductase inhibitors in mice
Authors
Keywords
Depression, Statins, Agmatine, Imidazoline receptors, FST, HMG-CoA reductase inhibitors
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 892, Issue -, Pages 173739
Publisher
Elsevier BV
Online
2020-11-18
DOI
10.1016/j.ejphar.2020.173739
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Simvastatin exerts antidepressant-like activity in mouse forced swimming test: Role of NO-cGMP-KATP channels pathway and PPAR-gamma receptors
- (2019) Reza Naserzadeh et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Atorvastatin prevents lipopolysaccharide-induced depressive-like behaviour in mice
- (2019) E.H. Taniguti et al. BRAIN RESEARCH BULLETIN
- Neuroprotective offerings by agmatine
- (2019) Nandkishor Ramdas Kotagale et al. NEUROTOXICOLOGY
- Inhibitory Influence of Agmatine in Ethanol Withdrawal-Induced Depression in Rats: Behavioral and Neurochemical Evidences
- (2019) Niyamat Chimthanawala et al. ALCOHOL
- Agmatine reverses ethanol consumption in rats: Evidences for an interaction with imidazoline receptors
- (2019) Brijesh G. Taksande et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Altered plasma levels of arginine metabolites in depression
- (2019) Arisoy Ozden et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Modulation of the anticonvulsant effect of swim stress by agmatine
- (2018) Taraneh Bahremand et al. EPILEPSY & BEHAVIOR
- Evidence of Reduced Agmatine Concentrations in the Cerebral Cortex of Suicides
- (2018) Gary G Chen et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Agmatine inhibits nicotine withdrawal induced cognitive deficits in inhibitory avoidance task in rats: Contribution of α 2 -adrenoceptors
- (2018) Nandkishor R. Kotagale et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The neuroprotective effect of agmatine against amyloid β-induced apoptosis in primary cultured hippocampal cells involving ERK, Akt/GSK-3β, and TNF-α
- (2018) Etrat Hooshmandi et al. MOLECULAR BIOLOGY REPORTS
- Agmatine attenuates intestinal ischemia and reperfusion injury by reducing oxidative stress and inflammatory reaction in rats
- (2017) Inci Turan et al. LIFE SCIENCES
- Therapeutic potential of agmatine for CNS disorders
- (2017) Vivian B. Neis et al. NEUROCHEMISTRY INTERNATIONAL
- Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling
- (2016) Vivian Binder Neis et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials
- (2016) Estela Salagre et al. JOURNAL OF AFFECTIVE DISORDERS
- Involvement of PI3K/Akt/GSK-3β and mTOR in the antidepressant-like effect of atorvastatin in mice
- (2016) Fabiana Kalyne Ludka et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Atorvastatin Protects from Aβ1–40-Induced Cell Damage and Depressive-Like Behavior via ProBDNF Cleavage
- (2016) Fabiana K. Ludka et al. MOLECULAR NEUROBIOLOGY
- Agmatine Prevents Adaptation of the Hippocampal Glutamate System in Chronic Morphine-Treated Rats
- (2016) Xiao-Fei Wang et al. Neuroscience Bulletin
- Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression
- (2016) E M Meylan et al. Translational Psychiatry
- Chronic agmatine treatment prevents behavioral manifestations of nicotine withdrawal in mice
- (2015) Nandkishor R. Kotagale et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Simvastatin prevents β-amyloid25–35-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate
- (2015) Conghui Wang et al. NEUROPHARMACOLOGY
- Statins Reduce the Risks of Relapse to Addiction in Rats
- (2015) Claudia Chauvet et al. NEUROPSYCHOPHARMACOLOGY
- Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-β1–40 Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems
- (2015) Wagner C. Martins et al. NEUROTOXICITY RESEARCH
- Agmatine attenuates nicotine induced conditioned place preference in mice through modulation of neuropeptide Y system
- (2014) Nandkishor R. Kotagale et al. BEHAVIOURAL BRAIN RESEARCH
- Depressive-like behavior induced by tumor necrosis factor-α is abolished by agmatine administration
- (2014) Vivian Binder Neis et al. BEHAVIOURAL BRAIN RESEARCH
- Imidazoline binding sites mediates anticompulsive-like effect of agmatine in marble-burying behavior in mice
- (2014) Madhura P. Dixit et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Antidepressant-like effect of atorvastatin in the forced swimming test in mice: The role of PPAR-gamma receptor and nitric oxide pathway
- (2014) Arash Shahsavarian et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats
- (2014) Brijesh G. Taksande et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice
- (2014) Andiara E. Freitas et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Statins in neurological disorders: An overview and update
- (2014) Anna Maria Malfitano et al. PHARMACOLOGICAL RESEARCH
- Atorvastatin evokes a serotonergic system-dependent antidepressant-like effect in mice
- (2014) Fabiana K. Ludka et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Agmatine: clinical applications after 100 years in translation
- (2013) John E. Piletz et al. DRUG DISCOVERY TODAY
- Agmatine attenuates chronic unpredictable mild stress induced behavioral alteration in mice
- (2013) Brijesh G. Taksande et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evidences for the agmatine involvement in antidepressant like effect of bupropion in mouse forced swim test
- (2013) Nandkishor R. Kotagale et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms
- (2012) Anil Kumar et al. BRAIN RESEARCH
- Acute atorvastatin treatment exerts antidepressant-like effect in mice via the l-arginine–nitric oxide–cyclic guanosine monophosphate pathway and increases BDNF levels
- (2012) Fabiana K. Ludka et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders
- (2011) Hans-Gert Bernstein et al. NEUROPHARMACOLOGY
- Repeated agmatine treatment attenuates nicotine sensitization in mice: Modulation by α2-adrenoceptors
- (2010) Nandkishor Ramdas Kotagale et al. BEHAVIOURAL BRAIN RESEARCH
- Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats
- (2010) Brijesh G Taksande et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β1–40 administration in mice: Evidence for dissociation between cognitive deficits and neuronal damage
- (2010) Tetsadê C.B. Piermartiri et al. EXPERIMENTAL NEUROLOGY
- Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine
- (2009) Brijesh G. Taksande et al. NEUROPHARMACOLOGY
- Platelet imidazoline receptors as state marker of depressive symptomatology
- (2006) John Piletz et al. JOURNAL OF PSYCHIATRIC RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation